Cardiac Angiosarcoma

Angiosarcoma is the most aggressive primary malignant cardiac tumor, typically involving the right atrium and characterized by its high invasiveness, rapid progression, and nonspecific clinical manifestations. The patient presented with recurrent hemorrhagic pericardial effusion and cardiac tamponade. Imaging revealed a right atrial mass, and intraoperative findings confirmed extensive invasion into the pericardium and adjacent structures, necessitating a partial palliative resection. Histopathological examination confirmed the diagnosis of angiosarcoma. After surgery, the patient received a combination regimen of chemotherapy, immunotherapy, and targeted therapy, with an overall survival of 11 months. A deeper understanding of this disease, clarification of the therapeutic challenges, and the development of evidence-based treatment guidelines are needed to provide more reliable and potentially life-saving strategies for patients with this disease.

Authors

Institutions

Publication Details

Journal
International Heart Journal
Published
2025-11-28
DOI
https://doi.org/10.1536/ihj.25-303
Primary Topic
Cardiac tumors and thrombi
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cardiac Angiosarcoma

Jian Yang, Chu Chen, Jing Zhang, Songlin Zhang
International Heart Journal
Cardiac tumors and thrombi
article

Cardiac Angiosarcoma

Jian Yang, Chu Chen, Jing Zhang, Songlin Zhang
article en

Abstract

Angiosarcoma is the most aggressive primary malignant cardiac tumor, typically involving the right atrium and characterized by its high invasiveness, rapid progression, and nonspecific clinical manifestations. The patient presented with recurrent hemorrhagic pericardial effusion and cardiac tamponade. Imaging revealed a right atrial mass, and intraoperative findings confirmed extensive invasion into the pericardium and adjacent structures, necessitating a partial palliative resection. Histopathological examination confirmed the diagnosis of angiosarcoma. After surgery, the patient received a combination regimen of chemotherapy, immunotherapy, and targeted therapy, with an overall survival of 11 months. A deeper understanding of this disease, clarification of the therapeutic challenges, and the development of evidence-based treatment guidelines are needed to provide more reliable and potentially life-saving strategies for patients with this disease.

International Heart JournalVol. 66(6)
Hubei Provincial Center for Disease Control and Prevention (CN), Yichang Central People's Hospital (CN), Wuhan Institute of Technology (CN)
Health Commission of Hubei Province, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province
Openalex Percentile: Top 45%
Cardiac tumors and thrombi
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cardiac Angiosarcoma — Jian Yang, Chu Chen, et al. · International Heart Journal (2025) | TGRS Research Map | TGRS